-
1
-
2
-
3
-
4
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study i...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
15
-
16
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the AT...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
17
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction ca...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
18
-
19
-
20
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivol...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel